memantine and taurine
memantine has been researched along with taurine in 11 studies
Research
Studies (11)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 8 (72.73) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kornhuber, J; Spanagel, R | 1 |
Mahal, B; Parsons, C; Pestel, E; Putzke, J; Rammes, G; Schadrack, J; Spanagel, R; Spielmanns, P; Zieglgänsberger, W | 1 |
Bespalov, A; Danysz, W; Kashkin, V; Malyshkin, A; Neznanova, O; Sukhotina, I; Zakharova, E | 1 |
Chawla, PS; Kochar, MS | 1 |
Borges, S; Flockhart, D; Preskorn, SH | 1 |
Howland, RH | 1 |
Melnikova, I | 1 |
Spangler, JG | 1 |
Bochenski, M; Kotlinska, J | 1 |
Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH | 1 |
Bhakoo, KK; Duytschaever, H; Garnell, JF; Grandjean, J; Sekar, S; Seramani, S; Su, H; Ver Donck, L; Willems, R | 1 |
Reviews
3 review(s) available for memantine and taurine
Article | Year |
---|---|
What's new in clinical pharmacology and therapeutics.
Topics: Acamprosate; Amyloid; Azabicyclo Compounds; Daptomycin; Diphosphonates; Drug Approval; Humans; Ibandronic Acid; Influenza Vaccines; Islet Amyloid Polypeptide; Ketolides; Lanthanum; Memantine; Pharmacology, Clinical; Piperazines; Rifamycins; Rifaximin; Scopolamine Derivatives; Taurine; Tiotropium Bromide; United States; United States Food and Drug Administration | 2006 |
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: part I.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Alzheimer Disease; Brain; Dopamine Agents; Humans; Memantine; Mental Disorders; Psychotropic Drugs; Taurine | 2006 |
Glutamate-modulating drugs & the treatment of mental disorders.
Topics: Acamprosate; Amantadine; Cycloserine; Glutamic Acid; Humans; Ketamine; Lamotrigine; Memantine; Mental Disorders; Psychotropic Drugs; Riluzole; Taurine; Triazines | 2007 |
Other Studies
8 other study(ies) available for memantine and taurine
Article | Year |
---|---|
[Glutamate receptor agonists and alcohol dependence. Preclinical findings].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Chronic Disease; Disease Models, Animal; Humans; Memantine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Secondary Prevention; Taurine | 1999 |
The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.
Topics: Acamprosate; Alcohol Deterrents; Animals; Brain; Cell Line; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Humans; Male; Memantine; N-Methylaspartate; Neurons; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Taurine; Xenopus | 2001 |
The NMDA receptor channel blocker memantine and opioid receptor antagonist naltrexone inhibit the saccharin deprivation effect in rats.
Topics: Acamprosate; Animals; Choice Behavior; Ethanol; Male; Memantine; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Saccharin; Substance Withdrawal Syndrome; Sweetening Agents; Taurine | 2004 |
Therapies for Alzheimer's disease.
Topics: Alzheimer Disease; Alzheimer Vaccines; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Cholinesterase Inhibitors; Clinical Trials as Topic; Excitatory Amino Acid Antagonists; GABA Agonists; Humans; Immunization; Memantine; Receptors, N-Methyl-D-Aspartate; Taurine | 2007 |
NMDA receptor blockade: a novel avenue for tobacco intervention?
Topics: Acamprosate; Central Nervous System Stimulants; Humans; Memantine; Models, Biological; Models, Theoretical; Neurons; Nicotiana; Nicotine; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Smoking Cessation; Taurine | 2008 |
The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
Topics: Acamprosate; Alcohol Deterrents; Animals; Anxiety; Behavior, Animal; Central Nervous System Depressants; Ethanol; Excitatory Amino Acid Antagonists; Male; Memantine; Pyridines; Quinolines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Taurine; Thiazoles | 2008 |
The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
Topics: Acamprosate; Amphetamine; Animals; Anxiety; Bridged Bicyclo Compounds; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Ligands; Male; Memantine; Pyridines; Rats; Receptors, Ionotropic Glutamate; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Taurine; Thiazoles | 2013 |
Neuro-metabolite profiles of rodent models of psychiatric dysfunctions characterised by MR spectroscopy.
Topics: Anhedonia; Animals; Choline; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutamine; Hippocampus; Inositol; Magnetic Resonance Spectroscopy; Male; Memantine; Motor Activity; Rats; Rats, Wistar; Schizophrenia; Stress, Psychological; Sucrose; Taurine | 2019 |